Amylase 30000 UNT / lipase 11000 UNT / protease 30000 UNT Oral Tablet [Ilozyme]
RxNorm 211581
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 211581 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: amylase 30000 UNT / lipase 11000 UNT / protease 30000 UNT Oral Tablet [Ilozyme].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 30000 UNT / lipase 11000 UNT / protease 30000 UNT Oral Tablet [Ilozyme]
(Atom ID: 12355427)
SY
Synonym (SY):
Ilozyme (amylase 30,000 UNT / lipase 11,000 UNT / protease 30,000 UNT) Oral Tablet
(Atom ID: 11845866)
SY